openPR Logo
Press release

OutIn Collaborates with BCRF to Launch Co-Branded Portable Espresso Machine

04-29-2024 06:04 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

OutIn Collaborates with BCRF to Launch Co-Branded Portable

OutIn & BCRF launch a co-branded espresso machine on April 29, donating 5% of revenue generated by each co-branded machine to BCRF.
Image: https://www.abnewswire.com/uploads/72a2c5e071a72887f921e241f9f74086.jpg

OutIn [https://outin.com/] proudly announces the launch of the new pink edition of OutIn Nano, a collaborative effort with the Breast Cancer Research Foundation (BCRF), on April 29. This initiative represents more than just the debut of a product; it symbolizes a significant commitment to preventing and curing breast cancer by advancing the world's most promising research.

The OutIn Nano is known for its portable design, enabling users to enjoy a rich, barista-quality espresso anywhere at any time. This model, which heats itself to deliver silky espresso within 200 seconds, now also supports an important cause. OutIn commits to donating 5% of the price of each co-branded Nano purchase to BCRF's research annually, with contributions rising to 10% between October 2024 and February 2025.

As the largest private funder of breast cancer research - and metastatic breast cancer research - globally, BCRF is dedicated to stopping breast cancer in its tracks. Breast cancer remains the most commonly diagnosed cancer and the leading cause of cancer death in women worldwide. Since its founding in 1993, BCRF has changed the trajectory of breast cancer by funding investigators who are behind every major breakthrough in lifesaving research.

OutIn's collaboration with BCRF highlights the company's commitment to more than just consumer products; it emphasizes a dedication to meaningful contributions to society. "Supporting BCRF isn't just about making donations; it's about making a difference. Every Nano purchase helps fund significant research that could eventually save lives," said Katja, Global Brand Director for OutIn. "We see this collaboration as a way to empower women to lead healthier lives beyond the threat of breast cancer."

By supporting BCRF, OutIn commits to supporting world-class research that is leading to better health outcomes. As the release date nears, OutIn encourages coffee lovers and supporters of breast cancer research to rally behind this impactful initiative. By supporting OutIn, customers will be contributing to the collective effort of supporting the brightest minds in breast cancer research.

Please visit www.outin.com [https://outin.com/] for any media or commercial inquiries.

For more information on BCRF, please visit www.bcrf.org [https://www.bcrf.org/].

For updates, follow Outin Inc. on Social Media:

Instagram @outin.inc.official

Facebook @outin.inc.eu.official

YouTube @outin.official

Twitter @outin_official

LinkedIn @OutIn Inc.

About Company:

Founded in Denver, Colorado, OutIn Inc. seeks to bring the comfort of home to all your journeys by providing reliable coffee-making solutions on the go. OutIn's portable electronic products have captivated thousands of coffee enthusiasts across the globe with their premium quality and stylish design. As an ESG-oriented company, OutIn actively engages in partnerships that aim to impact environmental and social issues positively. For more details, join OutIn Inc. at OutIn.com [http://outin.com].

About the Breast Cancer Research Foundation:

Breast cancer is a complex disease with no simple solution. Research is the key to stopping it in its tracks. Founded in 1993 by Evelyn H. Lauder, BCRF is the largest private funder of breast cancer research in the world. By investing in the best minds in science to examine every aspect of the disease from prevention to metastasis-and fostering cross-disciplinary collaboration-BCRF is accelerating the entire field and moving us closer to the answers we urgently need to be the end of breast cancer.

Media Contact
Company Name: OutIn Inc.
Contact Person: Katja
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=outin-collaborates-with-bcrf-to-launch-cobranded-portable-espresso-machine]
City: Denver
State: Colorado
Country: United States
Website: http://outin.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OutIn Collaborates with BCRF to Launch Co-Branded Portable Espresso Machine here

News-ID: 3478273 • Views:

More Releases from ABNewswire

PTFE Yarn with Low Heat-shrinkage for Multipurpose Weaving
PTFE Yarn with Low Heat-shrinkage for Multipurpose Weaving
Image: https://www.abnewswire.com/uploads/8c1f8a2c317a5c1991ed5a67179a0380.png Short Description: PTFE yarn [https://www.jinyoueptfe.com/] is a synthetic material that has gained popularity in various industries due to its unique properties. PTFE yarn has exceptional chemical resistance, high temperature resistance, and low friction properties. Product Introduction One of the most notable properties of PTFE yarn is its chemical resistance. It is highly resistant to most chemicals, including acids, bases, and solvents. This makes it an ideal material for use in chemical processing
Non-Alcoholic Steatohepatitis Market to Register Incremental Growth During the Forecast Period (2024-2034), Asserts DelveInsight | Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Viking
Non-Alcoholic Steatohepatitis Market to Register Incremental Growth During the F …
The Non-Alcoholic Steatohepatitis Market size was valued approximately USD 1,634 million in 2022 and the report offers an in-depth understanding of the Non-Alcoholic Steatohepatitis, historical and forecasted epidemiology as well as the Non-Alcoholic Steatohepatitis market trends in the 7MM. DelveInsight's "Non-Alcoholic Steatohepatitis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Non-Alcoholic Steatohepatitis, historical and forecasted epidemiology as well as the Non-Alcoholic Steatohepatitis market trends in the
ESR1 Mutated Metastatic Breast Cancer Market and Epidemiology 2032: Treatment Market, Therapies, FDA Approval, Epidemiology & Forecast by DelveInsight | Sanofi, Sun Pharma, Pfizer, Arvinas, Zenopharm
ESR1 Mutated Metastatic Breast Cancer Market and Epidemiology 2032: Treatment Ma …
The ESR1 Mutated Metastatic Breast Cancer Market Forecast report offers an in-depth understanding of the ESR1 Mutated Metastatic Breast Cancer, historical and forecasted epidemiology as well as the ESR1 Mutated Metastatic Breast Cancer market trends in the 7MM. ESR1 Mutated Metastatic Breast Cancer Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Radius Pharma/ Menarini Group, Pfizer, G1 Therapeutics, Sanofi, Sun Pharma, Advanced Research
Myasthenia Gravis Market to Exhibit Remarkable Growth During the Forecast Period (2024-2034), Analyzes DelveInsight | Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Hoffmann-La Roche, Janssen
Myasthenia Gravis Market to Exhibit Remarkable Growth During the Forecast Period …
The Myasthenia Gravis Market size was valued approximately USD 3,880 million in 2023 and the report offers an in-depth understanding of the Myasthenia Gravis, historical and forecasted epidemiology as well as the Myasthenia Gravis market trends in the 7MM. DelveInsight's "Myasthenia Gravis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Myasthenia Gravis, historical and forecasted epidemiology as well as the Myasthenia Gravis market trends in the

All 5 Releases